Lucid Diagnostics Inc.
LUCD
$1.26
-$0.03-2.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -133.15% | 6.71% | -12.41% | -3.70% | 2.01% |
| Total Depreciation and Amortization | -0.45% | 3.26% | -6.11% | -54.29% | -20.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,054.25% | -76.70% | 75.50% | 45.37% | 96.45% |
| Change in Net Operating Assets | -242.56% | 786.33% | 92.74% | 42.56% | -1,557.71% |
| Cash from Operations | -26.28% | 2.99% | 11.38% | 8.96% | -26.39% |
| Capital Expenditure | 64.09% | -- | -- | 100.00% | 78.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | 64.09% | 26.00% | -- | 100.00% | 78.86% |
| Total Debt Issued | -98.33% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -35.96% | 263.30% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.23% | 19,047.87% | -99.19% | -37.19% | 270.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.40% | 175.44% | -7,007.95% | -97.43% | 213.95% |